Sage Journals: Discover world-class research

Open access

Research article

First published 2024

Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes

Juan Carlos Caballero, Julio Dávila, María López-Pavía [...]

Therapeutic Advances in Hematology

Open access

Review article

First published 2021

Is 6-Shogaol an Effective Phytochemical for Patients With Lower-risk Myelodysplastic Syndrome? A Narrative Review

Soo Liang Ooi, Ron Campbell, Sok Cheon Pak [...]

Integrative Cancer Therapies

Open access

Research article

First published 2021

Discontinuation of the renin–angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes

George Pavlidis, Sotirios G. Papageorgiou, Efthimia Bazani [...]

Therapeutic Advances in Hematology

Open access

Review article

First published 2021

Treatment options for lower-risk myelodysplastic syndromes. Where are we now?

Virginia O. Volpe, Rami S. Komrokji

Therapeutic Advances in Hematology

Free access

Research article

First published 2006-12

Evolving Applications of Lenalidomide in the Management of Anemia in Myelodysplastic Syndromes

Alan F. List

Cancer Control

Free access

Review article

First published 2011-2

The revolution of myelodysplastic syndromes

Nelli Bejanyan, Mikkael A. Sekeres

Therapeutic Advances in Hematology

Open access

Research article

First published 2017

Evaluación Económica de Lenalidomida (Revlimid®) Para el Tratamiento Del Síndrome Mielodisplásico Con Deleción 5q de Riesgo Bajo/Intermedio-1

Christian Ramos, Efreen Montaño, Alfonso Reyes-López [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Open access

Review article

First published 2024

Hematopoietic Stem Cell Transplantation in the Management of Myelodysplastic Syndrome: A Retrospective,Current,and Future Perspective

Qimudesiren, Wenjie Yin, Yuhong Wang [...]

Cell Transplantation

Free access

Research article

First published 2008-10

Treatment Strategies to Optimize Clinical Benefit in the Patient with Myelodysplastic Syndromes

Alan F. List

Cancer Control

Retricted access

Research article

First published 2015-09

Abnormalities in the T Cell Receptor Vδ Repertoire and Foxp3 Expression in Refractory Anemia with Ringed Sideroblasts

Suxia Geng, Jianyu Weng, Shaohua Chen [...]

DNA and Cell Biology

Search results